RS
MDGL icon

Rakuten Securities’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rakuten Securities’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Sell
30
-2
-6% -$1.02K ﹤0.01% 393
2026
Q1 		$16.8K Buy
32
+2
+7% +$956 0.01% 369
2025
Q4 		$17.5K Hold
30
– – 0.01% 349
2025
Q3 		$13.8K Buy
30
+4
+15% +$1.49K 0.01% 364
2025
Q2 		$7.87K Buy
+26
New +$7.75K ﹤0.01% 439
2024
Q4 		– Sell
-5
Closed -$1.06K – 796
2024
Q3 		$1.06K Buy
+5
New +$1.28K ﹤0.01% 566

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rakuten Securities's MDGL Position: Q2 2026 in Review

Rakuten Securities reduced its Madrigal Pharmaceuticals (MDGL) stake by 6.3% in Q2 2026, selling an estimated $1.02K and leaving 30 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Rakuten Securities first reported a position in MDGL in Q3 2024 and has held it in 6 quarters since. The position peaked at $17.5K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Rakuten Securities held 30 shares of Madrigal Pharmaceuticals worth $16.1K as of Q2 2026.
  • Rakuten Securities sold 2 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.02K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #393 holding.
  • Rakuten Securities first reported a position in Madrigal Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Rakuten Securities's Madrigal Pharmaceuticals position peaked at $17.5K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.